Loading content
Dr Martin Pitt

Dr Martin Pitt

Associate Professor of Healthcare Modelling and Simulation

6082

South Cloisters 109

Research

Research interests

 Within the field of health services research, Martin Pitt’s specific focus is on the application of operational research methods (e.g. modelling, simulation, and forecasting) and health economic cost-effectiveness analysis.  Between 2003-2010, he work as part of PenTAG and developed cost-effectiveness models for use in health technology assessment for the National Institute of Health and Clinical Excellent (NICE). More recently, as Director of PenCHORD (Peninsula Collaboration for Health Operational Research and Development) he has led a wide range of initiatives in the application of these techniques across NHS trusts in Devon and Cornwall.

Martin has a long standing interest in the effective implementation of research in health services and specifically in the use of visualisation techniques to improve the communication of research to key user groups. In 2004 he established MASHnet (the UK Modelling and Simulation in Healthcare Network) which aims to build links between health service, research and commercial sectors in order to improve understanding and effective implementation of these techniques for Service Delivery.

In 2010 he was appointed Director of PenCHORD (www.penchord.org) which has been successful in developing  a wide range of effective modelling projects with health service trusts in Devon and Cornwall. This work has resulted in publications in high impact journals (see publications below). Within PenCHORD, Martin now manages a team of five researchers (with two more appointments pending) and led on a number of successful grant initiatives (see below) and has organised and presented his work at major national and international events.

Research projects

 Director of PenCHORD - Peninsula Collaboration for Health Operational Research and Development

PenCHORD is engaged in a range of projects looking at modelling health service and delivery to improve the NHS within the South-west of the UK.

Research networks

 Director of UK Modelling and Simulation Network (MASHnet)

Member of Cumberland Initiative (Healthcare Modelling)

Research grants

  • 2013 NIHR
    Neonatal Networks � The right cot in the right place at the right time. Simulation Modelling Project looking at the configuration of Neonatal networks in the South-west
  • 2011 South-West Heart and Stroke Clinical network
    Stoke and Cardiac Network Modelling Project

Key publications | Publications by category | Publications by year

Publications by category


Journal articles

Monks T, Worthington D, Allen M, Pitt M, Stein K, James MA (2016). A modelling tool for capacity planning in acute and community stroke services. BMC Health Serv Res, 16(1). Abstract.  Author URL.
Craig P, Rahm-Hallberg I, Britten N, Borglin G, Meyer G, Köpke S, Noyes J, Chandler J, Levati S, Sales A, et al (2016). Erratum to: Researching Complex Interventions in Health: the State of the Art. BMC Health Serv Res, 16(1). Author URL.  Full text.
(2016). Researching Complex Interventions in Health: the State of the Art : Exeter, UK. 14-15 October 2015. BMC Health Serv Res, 16 Suppl 1 Author URL.  Full text.
Pitt M, Monks T, Crowe S, Vasilakis C (2016). Systems modelling and simulation in health service design, delivery and decision making. BMJ Qual Saf, 25(1), 38-45. Abstract.  Author URL.
Monks T, Pearson M, Pitt M, Stein K, James MA (2015). Evaluating the impact of a simulation study in emergency stroke care. Operations Research for Health Care, 6, 40-49. Abstract.  Full text.
Chalk D, Pitt M (2015). Fractured neck of femur patients: Rehabilitation and the acute hospital. British Journal of Health Care Management, 21(3), 146-151. Abstract.
Allen M, Spencer A, Gibson A, Matthews J, Allwood A, Prosser S, Pitt M, Spencer AE (2015). Right cot, right place, right time: improving the design and organisation of neonatal care networks. Health service delivery research, 3(20). Full text.
Vasilakis C, Chaussalet T, Pitt M (2015). The 7th IMA international conference on quantitative modelling in the management of health and social care: IMA health 2013 special issue. Health Care Management Science, 18(2), 107-109. Abstract.
Chalk D, Pitt M (2015). The impact of minor injury unit closures on travel time and attendances. British Journal of Health Care Management, 21(5), 241-246. Abstract.
Chalk D, Pitt M, Stein K (2014). Cost-effectiveness of bevacizumab for diabetic macular oedema. British Journal of Health Care Management, 20(12), 585-593. Abstract.
Monks T, Pearson M, Pitt M, Stein K, James MA (2014). Evaluating the impact of a simulation study in emergency stroke care. Operations Research for Health Care Abstract.
Monks TMW, Pitt M, Stein K, James MA (2014). Hyperacute Stroke Care and NHS England's Business Plan. BMJ: British Medical Journal Author URL.
Monks T, Pitt M, Stein K, James MA (2014). Hyperacute stroke care and NHS England's business plan: Computer simulation, coupled with high quality data, can help in decision making. BMJ (Online), 348
Pitt M (2014). Systems Analysis Tools for Better Health Care Delivery. INTERFACES, 44(4), 434-435. Author URL.
Pearson M, Monks T, Gibson A, Allen M, Komashie A, Fordyce A, Harris-Golesworthy F, Pitt MA, Brailsford S, Stein K, et al (2013). Involving patients and the public in healthcare operational research-The challenges and opportunities. Operations Research for Health Care
Pearson M, Monks T, Gibson A, Allen M, Komashie A, Fordyce A, Harris-Golesworthy F, Pitt MA, Brailsford S, Stein K, et al (2013). Involving patients and the public in healthcare operational research-The challenges and opportunities. Operations Research for Health Care, 2 Abstract.
Brailsford SC, Bolt TB, Bucci G, Chaussalet TM, Connell NA, Harper PR, Klein JH, Pitt M, Taylor M (2013). Overcoming the barriers: a qualitative study of simulation adoption in the NHS. Journal of the Operational Research Society, 64(2), 157-168. Abstract.
Chalk D, Pitt M, Vaidya B, Stein K (2012). Can the retinal screening interval be safely increased to 2 years for type 2 diabetic patients without retinopathy?. Diabetes Care, 35(8), 1663-1668. Abstract.  Author URL.
Rogers G, Hoyle M, Thompson Coon J, Moxham T, Liu Z, Pitt M, Stein K (2012). Dasatinib and nilotinib for imatinib-resistant or -intolerant chronic myeloid leukaemia: a systematic review and economic evaluation. Health Technol Assess, 16(22), 1-410. Abstract.  Author URL.  Full text.
Monks T, Pitt M, Stein K, James M (2012). Maximizing the population benefit from thrombolysis in acute ischemic stroke: a modeling study of in-hospital delays. Stroke, 43(10), 2706-2711. Abstract.  Author URL.
Pitt M, Monks T, Agarwal P, Worthington D, Ford GA, Lees KR, Stein K, James MA (2012). Will delays in treatment jeopardize the population benefit from extending the time window for stroke thrombolysis?. Stroke, 43(11), 2992-2997. Abstract.  Author URL.
Pitt M, Crathorne L, Moxham T, Bond M, Hyde C (2010). Everolimus for the second-line treatment of advanced and/or metastatic renal cell cancer: a critique of the submission from Novartis. Health technology assessment (Winchester, England), 14(Suppl. 2), 41-46. Abstract.
Pitt M, Crathorne L, Moxham T, Bond M, Hyde C (2010). Everolimus for the second-line treatment of advanced and/or metastatic renal cell cancer: a critique of the submission from Novartis. Health Technol Assess, 14(Suppl. 2), 41-46. Abstract.  Author URL.
Stahl-Timmins W, Pitt M, Peters J (2010). Graphical presentation of data for health policy decisions: an exploratory online decision task experiment to measure efectiveness. Information Design Journal, 18(3), 205-224. Abstract.
Woodman J, Lecky F, Hodes D, Pitt M, Taylor B, Gilbert R (2010). Screening injured children for physical abuse or neglect in emergency departments: a systematic review. Child: Care, Health and Development, 36(2), 153-164. Abstract.
Main C, Pitt M, Moxham T, Stein K (2010). The clinical effectiveness and cost-effectiveness of rituximab for the first-line treatment of chronic lymphocytic leukaemia: an evidence review of the submission from Roche. Health Technol Assess, 14(Suppl. 2), 27-32. Abstract.  Author URL.
Main C, Pitt M, Moxham T, Stein K (2010). The clinical effectiveness and cost-effectiveness of rituximab for the first-line treatment of chronic lymphocytic leukaemia: an evidence review of the submission from Roche. Health technology assessment (Winchester, England), 14(Suppl. 2), 27-32. Abstract.
Brailsford SC, Harper PR, Patel B, Pitt M (2009). An analysis of the academic literature on simulation and modelling in health care. Journal of Simulation, 3(3), 130-140. Abstract.
Pitt MA, Dodds S, Bensley D, Royston G, Stein K (2009). The Potential of Operational Research. British Journal of Healthcare management, 15(1), 22-27.
Bond M, Pitt M, Akoh J, Moxham T, Hoyle M, Anderson R (2009). The effectiveness and cost-effectiveness of methods of storing donated kidneys from deceased donors: a systematic review and economic model. Health Technology Assessment, 13(38). Abstract.
Bond M, Pitt M, Akoh J, Moxham T, Hoyle M, Anderson R (2009). The effectiveness and cost-effectiveness of methods of storing donated kidneys from deceased donors: a systematic review and economic model. Health Technol Assess, 13(38), iii-156. Abstract.  Author URL.
Pitt M, Stahl-Timmins W, Anderson R, Stein K (2009). Using information graphics in health technology assessment: toward a structured approach. Int J Technol Assess Health Care, 25(4), 555-563. Abstract.  Author URL.
Rogers G, Garside R, Mealing S, Pitt M, Anderson R, Dyer M, Stein K, Somerville M (2008). Carmustine implants for the treatment of newly diagnosed high-grade gliomas: a cost-utility analysis. Pharmacoeconomics, 26(1), 33-44. Abstract.  Author URL.
Woodman J, Pitt M, Wentz R, Taylor B, Hodes D, Gilbert RE (2008). Performance of screening tests for child physical abuse in accident and emergency departments. Health Technol Assess, 12(33). Abstract.  Author URL.
Somerville M, Garside R, Pitt M, Stein K (2008). Surveillance of Barrett's oesophagus: is it worthwhile?. Eur J Cancer, 44(4), 588-599. Abstract.  Author URL.
Shepherd J, Rogers G, Anderson R, Main C, Thompson-Coon J, Hartwell D, Liu Z, Loveman E, Green C, Pitt M, et al (2008). Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in adults and children aged 12 years and over. Health Technol Assess, 12(19), iii-360. Abstract.  Author URL.  Full text.
Main C, Shepherd J, Anderson R, Rogers G, Thompson-Coon J, Liu Z, Hartwell D, Loveman E, Green C, Pitt M, et al (2008). Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in children under the age of 12 years. Health Technol Assess, 12(20), 1-iv. Abstract.  Author URL.  Full text.
Garside R, Anderson R, Pitt M, Mealing S, D'Souza R, Stein K (2007). Costutility analysis of cinacalcet in addition to standard of care in the UK - Reply. NEPHROLOGY DIALYSIS TRANSPLANTATION, 22(11), 3357-3358. Author URL.
Garside R, Anderson R, Pitt M, Mealing S, D'Souza R, Stein K (2007). Reply [4]. Nephrology Dialysis Transplantation, 22(11), 3357-3358.
Garside R, Pitt M, Anderson R, Mealing S, D'Souza R, Stein K (2007). The cost-utility of cinacalcet in addition to standard care compared to standard care alone for secondary hyperparathyroidism in end-stage renal disease: a UK perspective. Nephrol Dial Transplant, 22(5), 1428-1436. Abstract.  Author URL.
Pitt MA, Anderson R, Garside R, Stein K (2007). The effectiveness and cost-effectiveness of carmustine implants and temozolamide for the treatment of newly diagnosed high grade gliomas: a systematic review and economic model.
Garside R, Pitt M, Anderson R, Rogers G, Dyer M, Mealing S, Somerville M, Price A, Stein K (2007). The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation. Health technology assessment (Winchester, England), 11(45). Abstract.
Garside R, Pitt M, Anderson R, Rogers G, Dyer M, Mealing S, Somerville M, Price A, Stein K (2007). The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation. Health Technol Assess, 11(45), iii-221. Abstract.  Author URL.
Garside R, Pitt M, Anderson R, Mealing S, Roome C, Snaith A, D'Souza R, Welch K, Stein K (2007). The effectiveness and cost-effectiveness of cinacalcet for secondary hyperparathyroidism in end-stage renal disease patients on dialysis: a systematic review and economic evaluation. Health Technology Assessment, 11(18). Abstract.
Garside R, Pitt M, Anderson R, Mealing S, Roome C, Snaith A, D'Souza R, Welch K, Stein K (2007). The effectiveness and cost-effectiveness of cinacalcet for secondary hyperparathyroidism in end-stage renal disease patients on dialysis: a systematic review and economic evaluation. Health technology assessment (Winchester, England), 11(18). Abstract.
Pitt M, Garside R, Stein K (2006). A cost-utility analysis of pimecrolimus vs. topical corticosteroids and emollients for the treatment of mild and moderate atopic eczema. Br J Dermatol, 154(6), 1137-1146. Abstract.  Author URL.
Thompson Coon J, Castelnuovo E, Pitt M, Cramp M, Siebert U, Stein K (2006). Case finding for hepatitis C in primary care: a cost utility analysis. Fam Pract, 23(4), 393-406. Abstract.  Author URL.
Garside R, Pitt M, Somerville M, Stein K, Price A, Gilbert N (2006). Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling. Health Technol Assess, 10(8), 1-iv. Abstract.  Author URL.
Garside R, Pitt M, Somerville M, Stein K, Price A, Gilbert N (2006). Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling. Health technology assessment (Winchester, England), 10(8). Abstract.
Castelnuovo E, Thompson-Coon J, Pitt M, Cramp M, Siebert U, Price A, Stein K (2006). The cost-effectiveness of testing for hepatitis C in former injecting drug users. Health technology assessment (Winchester, England), 10(32). Abstract.
Pitt MA, Garside R, Somerville M, Stein K (2005). Surveillance of Barrett's Oesophagus: Exploring the uncertainty through systematic review, expert workshop and economic modelling.
Pitt MA, Castelnuovo E, Stein K, Garside R (2005). The effectiveness and cost-effectiveness of dual-chamber pacemakers compared with single-chamber pacemakers for bradycardia due to atrioventricular block or sick sinus syndrome: systematic review and economic evaluation.
Castelnuovo E, Stein K, Pitt M, Garside R, Payne E (2005). The effectiveness and cost-effectiveness of dual-chamber pacemakers compared with single-chamber pacemakers for bradycardia due to atrioventricular block or sick sinus syndrome: systematic review and economic evaluation. Health Technol Assess, 9(43), iii-246. Abstract.  Author URL.
Garside R, Stein K, Castelnuovo E, Pitt M, Ashcroft D, Dimmock P, Payne L (2005). The effectiveness and cost-effectiveness of pimecrolimus and tacrolimus for atopic eczema: a systematic review and economic evaluation. Health Technol Assess, 9(29), iii-230. Abstract.  Author URL.
Garside R, Stein K, Wyatt K, Round A, Pitt MA (2004). A Cost-utility Analysis of Microwave and Thermal Balloon Ablation for Heavy Menstrual Bleeding. BJOG, 111, 1103-1114.
Garside R, Stein K, Wyatt K, Round A, Pitt M (2004). A cost-utility analysis of microwave and thermal balloon endometrial ablation techniques for the treatment of heavy menstrual bleeding. BJOG, 111(10), 1103-1114. Abstract.  Author URL.
Harper PR, Pitt MA (2004). On the challenges of healthcare modelling and a proposed project life cycle for successful implementation. Journal of the Operational Research Society, 55(6), 657-661. Abstract.

Conferences

Manzi S, Chalk D, Pearson M, Day J, Stein K, Lang I, Pitt M (2016). Opening the black box: Combining agent based simulation and realism in intervention development.  Abstract.
Rachuba S, Salmon A, Zhelev Z, Pitt M (2016). Simulating single test rule-out strategies for chest pain patients at emergency departments.  Abstract.
Mealing SJ, Garside R, Pitt M, Anderson R, D'Sousa R, Stein K (2006). A cost-utility analysis in a UK setting of cinacalcet for secondary hyperparathyroidism in end stage renal disease.  Author URL.
Pitt M (1998). A generic approach to simulation in healthcare management.  Author URL.

Reports

Pitt M, Crathorne L, Moxham T, Bond M, Hyde C (2009). Everolimus for the second-line treatment of advanced and/or metastatic renal cell carcinoma. NIHR HTA, NICE.
Bond M, Pitt M, Akoh J, Moxham T, Hoyle M, Anderson R (2008). The effectiveness and cost-effectiveness of methods of storing donated kidneys from deceased donors: a systematic review and economic model. NIHR HTA, NICE.
Castelnuovo E, Thompson-Coon J, Pitt M, Cramp M, Siebert U, Price A, Stein K (2006). The cost-effectiveness of testing for hepatitis C in former injecting drug users. Abstract.

Publications by year


2016

Monks T, Worthington D, Allen M, Pitt M, Stein K, James MA (2016). A modelling tool for capacity planning in acute and community stroke services. BMC Health Serv Res, 16(1). Abstract.  Author URL.
Craig P, Rahm-Hallberg I, Britten N, Borglin G, Meyer G, Köpke S, Noyes J, Chandler J, Levati S, Sales A, et al (2016). Erratum to: Researching Complex Interventions in Health: the State of the Art. BMC Health Serv Res, 16(1). Author URL.  Full text.
Manzi S, Chalk D, Pearson M, Day J, Stein K, Lang I, Pitt M (2016). Opening the black box: Combining agent based simulation and realism in intervention development.  Abstract.
(2016). Researching Complex Interventions in Health: the State of the Art : Exeter, UK. 14-15 October 2015. BMC Health Serv Res, 16 Suppl 1 Author URL.  Full text.
Rachuba S, Salmon A, Zhelev Z, Pitt M (2016). Simulating single test rule-out strategies for chest pain patients at emergency departments.  Abstract.
Pitt M, Monks T, Crowe S, Vasilakis C (2016). Systems modelling and simulation in health service design, delivery and decision making. BMJ Qual Saf, 25(1), 38-45. Abstract.  Author URL.

2015

Monks T, Pearson M, Pitt M, Stein K, James MA (2015). Evaluating the impact of a simulation study in emergency stroke care. Operations Research for Health Care, 6, 40-49. Abstract.  Full text.
Chalk D, Pitt M (2015). Fractured neck of femur patients: Rehabilitation and the acute hospital. British Journal of Health Care Management, 21(3), 146-151. Abstract.
Allen M, Spencer A, Gibson A, Matthews J, Allwood A, Prosser S, Pitt M, Spencer AE (2015). Right cot, right place, right time: improving the design and organisation of neonatal care networks. Health service delivery research, 3(20). Full text.
Vasilakis C, Chaussalet T, Pitt M (2015). The 7th IMA international conference on quantitative modelling in the management of health and social care: IMA health 2013 special issue. Health Care Management Science, 18(2), 107-109. Abstract.
Chalk D, Pitt M (2015). The impact of minor injury unit closures on travel time and attendances. British Journal of Health Care Management, 21(5), 241-246. Abstract.

2014

Chalk D, Pitt M, Stein K (2014). Cost-effectiveness of bevacizumab for diabetic macular oedema. British Journal of Health Care Management, 20(12), 585-593. Abstract.
Monks T, Pearson M, Pitt M, Stein K, James MA (2014). Evaluating the impact of a simulation study in emergency stroke care. Operations Research for Health Care Abstract.
Monks TMW, Pitt M, Stein K, James MA (2014). Hyperacute Stroke Care and NHS England's Business Plan. BMJ: British Medical Journal Author URL.
Monks T, Pitt M, Stein K, James MA (2014). Hyperacute stroke care and NHS England's business plan: Computer simulation, coupled with high quality data, can help in decision making. BMJ (Online), 348
Pitt M (2014). Systems Analysis Tools for Better Health Care Delivery. INTERFACES, 44(4), 434-435. Author URL.

2013

Pearson M, Monks T, Gibson A, Allen M, Komashie A, Fordyce A, Harris-Golesworthy F, Pitt MA, Brailsford S, Stein K, et al (2013). Involving patients and the public in healthcare operational research-The challenges and opportunities. Operations Research for Health Care
Pearson M, Monks T, Gibson A, Allen M, Komashie A, Fordyce A, Harris-Golesworthy F, Pitt MA, Brailsford S, Stein K, et al (2013). Involving patients and the public in healthcare operational research-The challenges and opportunities. Operations Research for Health Care, 2 Abstract.
Brailsford SC, Bolt TB, Bucci G, Chaussalet TM, Connell NA, Harper PR, Klein JH, Pitt M, Taylor M (2013). Overcoming the barriers: a qualitative study of simulation adoption in the NHS. Journal of the Operational Research Society, 64(2), 157-168. Abstract.

2012

Chalk D, Pitt M, Vaidya B, Stein K (2012). Can the retinal screening interval be safely increased to 2 years for type 2 diabetic patients without retinopathy?. Diabetes Care, 35(8), 1663-1668. Abstract.  Author URL.
Rogers G, Hoyle M, Thompson Coon J, Moxham T, Liu Z, Pitt M, Stein K (2012). Dasatinib and nilotinib for imatinib-resistant or -intolerant chronic myeloid leukaemia: a systematic review and economic evaluation. Health Technol Assess, 16(22), 1-410. Abstract.  Author URL.  Full text.
Monks T, Pitt M, Stein K, James M (2012). Maximizing the population benefit from thrombolysis in acute ischemic stroke: a modeling study of in-hospital delays. Stroke, 43(10), 2706-2711. Abstract.  Author URL.
Pitt M, Monks T, Agarwal P, Worthington D, Ford GA, Lees KR, Stein K, James MA (2012). Will delays in treatment jeopardize the population benefit from extending the time window for stroke thrombolysis?. Stroke, 43(11), 2992-2997. Abstract.  Author URL.

2010

Pitt M, Crathorne L, Moxham T, Bond M, Hyde C (2010). Everolimus for the second-line treatment of advanced and/or metastatic renal cell cancer: a critique of the submission from Novartis. Health technology assessment (Winchester, England), 14(Suppl. 2), 41-46. Abstract.
Pitt M, Crathorne L, Moxham T, Bond M, Hyde C (2010). Everolimus for the second-line treatment of advanced and/or metastatic renal cell cancer: a critique of the submission from Novartis. Health Technol Assess, 14(Suppl. 2), 41-46. Abstract.  Author URL.
Stahl-Timmins W, Pitt M, Peters J (2010). Graphical presentation of data for health policy decisions: an exploratory online decision task experiment to measure efectiveness. Information Design Journal, 18(3), 205-224. Abstract.
Woodman J, Lecky F, Hodes D, Pitt M, Taylor B, Gilbert R (2010). Screening injured children for physical abuse or neglect in emergency departments: a systematic review. Child: Care, Health and Development, 36(2), 153-164. Abstract.
Main C, Pitt M, Moxham T, Stein K (2010). The clinical effectiveness and cost-effectiveness of rituximab for the first-line treatment of chronic lymphocytic leukaemia: an evidence review of the submission from Roche. Health Technol Assess, 14(Suppl. 2), 27-32. Abstract.  Author URL.
Main C, Pitt M, Moxham T, Stein K (2010). The clinical effectiveness and cost-effectiveness of rituximab for the first-line treatment of chronic lymphocytic leukaemia: an evidence review of the submission from Roche. Health technology assessment (Winchester, England), 14(Suppl. 2), 27-32. Abstract.

2009

Brailsford SC, Harper PR, Patel B, Pitt M (2009). An analysis of the academic literature on simulation and modelling in health care. Journal of Simulation, 3(3), 130-140. Abstract.
Pitt M, Crathorne L, Moxham T, Bond M, Hyde C (2009). Everolimus for the second-line treatment of advanced and/or metastatic renal cell carcinoma. NIHR HTA, NICE.
Pitt MA, Dodds S, Bensley D, Royston G, Stein K (2009). The Potential of Operational Research. British Journal of Healthcare management, 15(1), 22-27.
Bond M, Pitt M, Akoh J, Moxham T, Hoyle M, Anderson R (2009). The effectiveness and cost-effectiveness of methods of storing donated kidneys from deceased donors: a systematic review and economic model. Health Technology Assessment, 13(38). Abstract.
Bond M, Pitt M, Akoh J, Moxham T, Hoyle M, Anderson R (2009). The effectiveness and cost-effectiveness of methods of storing donated kidneys from deceased donors: a systematic review and economic model. Health Technol Assess, 13(38), iii-156. Abstract.  Author URL.
Pitt M, Stahl-Timmins W, Anderson R, Stein K (2009). Using information graphics in health technology assessment: toward a structured approach. Int J Technol Assess Health Care, 25(4), 555-563. Abstract.  Author URL.

2008

Rogers G, Garside R, Mealing S, Pitt M, Anderson R, Dyer M, Stein K, Somerville M (2008). Carmustine implants for the treatment of newly diagnosed high-grade gliomas: a cost-utility analysis. Pharmacoeconomics, 26(1), 33-44. Abstract.  Author URL.
Woodman J, Pitt M, Wentz R, Taylor B, Hodes D, Gilbert RE (2008). Performance of screening tests for child physical abuse in accident and emergency departments. Health Technol Assess, 12(33). Abstract.  Author URL.
Somerville M, Garside R, Pitt M, Stein K (2008). Surveillance of Barrett's oesophagus: is it worthwhile?. Eur J Cancer, 44(4), 588-599. Abstract.  Author URL.
Shepherd J, Rogers G, Anderson R, Main C, Thompson-Coon J, Hartwell D, Liu Z, Loveman E, Green C, Pitt M, et al (2008). Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in adults and children aged 12 years and over. Health Technol Assess, 12(19), iii-360. Abstract.  Author URL.  Full text.
Main C, Shepherd J, Anderson R, Rogers G, Thompson-Coon J, Liu Z, Hartwell D, Loveman E, Green C, Pitt M, et al (2008). Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in children under the age of 12 years. Health Technol Assess, 12(20), 1-iv. Abstract.  Author URL.  Full text.
Bond M, Pitt M, Akoh J, Moxham T, Hoyle M, Anderson R (2008). The effectiveness and cost-effectiveness of methods of storing donated kidneys from deceased donors: a systematic review and economic model. NIHR HTA, NICE.

2007

Garside R, Anderson R, Pitt M, Mealing S, D'Souza R, Stein K (2007). Costutility analysis of cinacalcet in addition to standard of care in the UK - Reply. NEPHROLOGY DIALYSIS TRANSPLANTATION, 22(11), 3357-3358. Author URL.
Garside R, Anderson R, Pitt M, Mealing S, D'Souza R, Stein K (2007). Reply [4]. Nephrology Dialysis Transplantation, 22(11), 3357-3358.
Garside R, Pitt M, Anderson R, Mealing S, D'Souza R, Stein K (2007). The cost-utility of cinacalcet in addition to standard care compared to standard care alone for secondary hyperparathyroidism in end-stage renal disease: a UK perspective. Nephrol Dial Transplant, 22(5), 1428-1436. Abstract.  Author URL.
Pitt MA, Anderson R, Garside R, Stein K (2007). The effectiveness and cost-effectiveness of carmustine implants and temozolamide for the treatment of newly diagnosed high grade gliomas: a systematic review and economic model.
Garside R, Pitt M, Anderson R, Rogers G, Dyer M, Mealing S, Somerville M, Price A, Stein K (2007). The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation. Health technology assessment (Winchester, England), 11(45). Abstract.
Garside R, Pitt M, Anderson R, Rogers G, Dyer M, Mealing S, Somerville M, Price A, Stein K (2007). The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation. Health Technol Assess, 11(45), iii-221. Abstract.  Author URL.
Garside R, Pitt M, Anderson R, Mealing S, Roome C, Snaith A, D'Souza R, Welch K, Stein K (2007). The effectiveness and cost-effectiveness of cinacalcet for secondary hyperparathyroidism in end-stage renal disease patients on dialysis: a systematic review and economic evaluation. Health Technology Assessment, 11(18). Abstract.
Garside R, Pitt M, Anderson R, Mealing S, Roome C, Snaith A, D'Souza R, Welch K, Stein K (2007). The effectiveness and cost-effectiveness of cinacalcet for secondary hyperparathyroidism in end-stage renal disease patients on dialysis: a systematic review and economic evaluation. Health technology assessment (Winchester, England), 11(18). Abstract.

2006

Mealing SJ, Garside R, Pitt M, Anderson R, D'Sousa R, Stein K (2006). A cost-utility analysis in a UK setting of cinacalcet for secondary hyperparathyroidism in end stage renal disease.  Author URL.
Pitt M, Garside R, Stein K (2006). A cost-utility analysis of pimecrolimus vs. topical corticosteroids and emollients for the treatment of mild and moderate atopic eczema. Br J Dermatol, 154(6), 1137-1146. Abstract.  Author URL.
Thompson Coon J, Castelnuovo E, Pitt M, Cramp M, Siebert U, Stein K (2006). Case finding for hepatitis C in primary care: a cost utility analysis. Fam Pract, 23(4), 393-406. Abstract.  Author URL.
Garside R, Pitt M, Somerville M, Stein K, Price A, Gilbert N (2006). Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling. Health Technol Assess, 10(8), 1-iv. Abstract.  Author URL.
Garside R, Pitt M, Somerville M, Stein K, Price A, Gilbert N (2006). Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling. Health technology assessment (Winchester, England), 10(8). Abstract.
Castelnuovo E, Thompson-Coon J, Pitt M, Cramp M, Siebert U, Price A, Stein K (2006). The cost-effectiveness of testing for hepatitis C in former injecting drug users. Abstract.
Castelnuovo E, Thompson-Coon J, Pitt M, Cramp M, Siebert U, Price A, Stein K (2006). The cost-effectiveness of testing for hepatitis C in former injecting drug users. Health technology assessment (Winchester, England), 10(32). Abstract.

2005

Pitt MA, Garside R, Somerville M, Stein K (2005). Surveillance of Barrett's Oesophagus: Exploring the uncertainty through systematic review, expert workshop and economic modelling.
Pitt MA, Castelnuovo E, Stein K, Garside R (2005). The effectiveness and cost-effectiveness of dual-chamber pacemakers compared with single-chamber pacemakers for bradycardia due to atrioventricular block or sick sinus syndrome: systematic review and economic evaluation.
Castelnuovo E, Stein K, Pitt M, Garside R, Payne E (2005). The effectiveness and cost-effectiveness of dual-chamber pacemakers compared with single-chamber pacemakers for bradycardia due to atrioventricular block or sick sinus syndrome: systematic review and economic evaluation. Health Technol Assess, 9(43), iii-246. Abstract.  Author URL.
Garside R, Stein K, Castelnuovo E, Pitt M, Ashcroft D, Dimmock P, Payne L (2005). The effectiveness and cost-effectiveness of pimecrolimus and tacrolimus for atopic eczema: a systematic review and economic evaluation. Health Technol Assess, 9(29), iii-230. Abstract.  Author URL.

2004

Garside R, Stein K, Wyatt K, Round A, Pitt MA (2004). A Cost-utility Analysis of Microwave and Thermal Balloon Ablation for Heavy Menstrual Bleeding. BJOG, 111, 1103-1114.
Garside R, Stein K, Wyatt K, Round A, Pitt M (2004). A cost-utility analysis of microwave and thermal balloon endometrial ablation techniques for the treatment of heavy menstrual bleeding. BJOG, 111(10), 1103-1114. Abstract.  Author URL.
Harper PR, Pitt MA (2004). On the challenges of healthcare modelling and a proposed project life cycle for successful implementation. Journal of the Operational Research Society, 55(6), 657-661. Abstract.

1998

Pitt M (1998). A generic approach to simulation in healthcare management.  Author URL.

Back | Edit Profile